Imunon, Inc. (IMNN)
NASDAQ: IMNN · IEX Real-Time Price · USD
1.345
-0.135 (-9.12%)
At close: May 14, 2024, 4:00 PM
1.480
+0.135 (10.04%)
After-hours: May 14, 2024, 6:43 PM EDT
Imunon Market Cap
Imunon has a market cap or net worth of $12.64 million as of May 14, 2024. Its market cap has increased by 0.34% in one year.
Market Cap
12.64M
Enterprise Value
4.34M
1-Year Change
0.34%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.80M to $12.64M, a decrease of -66.55%. That is a compound annual growth rate of -4.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 14, 2024 | 12.60M | -9.35% |
May 13, 2024 | 13.90M | 6.92% |
May 10, 2024 | 13.00M | -8.45% |
May 9, 2024 | 14.20M | 0.71% |
May 8, 2024 | 14.10M | 17.50% |
May 7, 2024 | 12.00M | -2.44% |
May 6, 2024 | 12.30M | -1.60% |
May 3, 2024 | 12.50M | 1.63% |
May 2, 2024 | 12.30M | - |
May 1, 2024 | 12.30M | - |
Apr 30, 2024 | 12.30M | -3.15% |
Apr 29, 2024 | 12.70M | -5.93% |
Apr 26, 2024 | 13.50M | - |
Apr 25, 2024 | 13.50M | 10.66% |
Apr 24, 2024 | 12.20M | -2.40% |
Apr 23, 2024 | 12.50M | 5.04% |
Apr 22, 2024 | 11.90M | 8.18% |
Apr 19, 2024 | 11.00M | 3.77% |
Apr 18, 2024 | 10.60M | -0.93% |
Apr 17, 2024 | 10.70M | -17.05% |
Apr 16, 2024 | 12.90M | -6.52% |
Apr 15, 2024 | 13.80M | -7.38% |
Apr 12, 2024 | 14.90M | 2.76% |
Apr 11, 2024 | 14.50M | 6.62% |
Apr 10, 2024 | 13.60M | -6.85% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BIMI International Medical | 12.98M |
Check-Cap | 12.81M |
Chromocell Therapeutics | 12.75M |
Eterna Therapeutics | 12.71M |
Cosmos Health | 12.68M |
Trinity Biotech | 12.62M |
NewGenIvf Group | 12.59M |
Chemomab Therapeutics | 12.51M |